Enzo Biochem Inc
ENZBDelisted Apr 7, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000316253
Enzo Biochem Inc was delisted on Apr 7, 2025; its insiders filed their last Form 4 on Aug 20, 2025; 41 institutions reported holding it in 13F filings for Q1 2025, worth $4.96M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Enzo Biochem Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −4 vs. Q4 2023
- Shares held
- 13.8M
- −1.05M (−7.1%) vs. Q4 2023
- Total value
- $17.6M
- −$3.12M (−15.1%) vs. Q4 2023
- New holders
- 6
- 3 more added
- Sold out
- 10
- 11 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENZB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 7 | $2.00M |
| Q1 2025 | 41 | $4.96M |
| Q4 2024 | 44 | $9.71M |
| Q3 2024 | 43 | $14.2M |
| Q2 2024 | 39 | $13.5M |
| Q1 2024 | 41 | $17.6M |
| Q4 2023 | 46 | $22.7M |
| Q3 2023 | 39 | $23.1M |
| Q2 2023 | 47 | $34.7M |
| Q1 2023 | 52 | $48.1M |
| Q4 2022 | 52 | $26.8M |
| Q3 2022 | 49 | $45.6M |
| Q2 2022 | 54 | $43.8M |
| Q1 2022 | 51 | $62.0M |
| Q4 2021 | 59 | $69.0M |
| Q3 2021 | 65 | $82.9M |
| Q2 2021 | 72 | $76.6M |
| Q1 2021 | 82 | $94.6M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Enzo Biochem Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Benjamin Edwards Inc | 300 | $0 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 10 | $13 | 0.00% | 00.0% | Unchanged |
| Sound Income Strategies, LLC | 10 | $13 | 0.00% | +10 | New |
| Clear Point Advisors Inc. | 120 | $152 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 278 | $353 | 0.00% | −1,596−85.2% | Reduced |
| Royal Bank of Canada | 1,081 | $1.00K | 0.00% | −232−17.7% | Reduced |
| Simplex Trading, LLC | 881 | $1.00K | 0.00% | +881 | New |
| Wells Fargo & Company | 882 | $1.12K | 0.00% | −420−32.3% | Reduced |
| Advisor Group Holdings, Inc. | 1,123 | $1.43K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,833 | $2.33K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,985 | $2.52K | 0.00% | +1,555+361.6% | Added |
| Bank of America Corp | 2,388 | $3.03K | 0.00% | −724−23.3% | Reduced |
| BFSG, LLC | 2,813 | $3.57K | 0.00% | +2,813 | New |
| Covestor Ltd | 3,967 | $5.00K | 0.00% | 00.0% | Unchanged |
| Nierenberg Investment Management Company, Inc. | 11,555 | $14.7K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 12,113 | $15.4K | 0.00% | +3,828+46.2% | Added |
| Charles Schwab Investment Management Inc | 13,471 | $17.1K | 0.00% | 00.0% | Unchanged |
| Sage Mountain Advisors LLC | 14,195 | $18.0K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 14,527 | $18.4K | 0.00% | +14,527 | New |
| Shulman DeMeo Asset Management LLC | 15,487 | $19.7K | 0.01% | 00.0% | Unchanged |
| Raymond James Trust N.A. | 17,016 | $21.6K | 0.00% | 00.0% | Unchanged |
| PFG Investments, LLC | 18,662 | $23.7K | 0.00% | +18,662 | New |
| Paradigm Financial Partners, LLC | 19,500 | $24.8K | 0.01% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 19,773 | $25.1K | 0.00% | −52,643−72.7% | Reduced |
| Snowden Capital Advisors LLC | 20,445 | $26.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 24,270 | $30.8K | 0.00% | +24,270 | New |
| Kempner Capital Management Inc. | 25,475 | $32.0K | 0.02% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 44,800 | $57.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 67,258 | $85.4K | 0.00% | −46,068−40.7% | Reduced |
| Wittenberg Investment Management, Inc. | 68,003 | $86.4K | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 71,755 | $91.1K | 0.00% | −4,000−5.3% | Reduced |
| State Street Corp | 154,139 | $195.8K | 0.00% | −12,900−7.7% | Reduced |
| Bridgeway Capital Management, LLC | 227,100 | $288.4K | 0.01% | 00.0% | Unchanged |
| RBF Capital, LLC | 250,359 | $318.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 337,856 | $429.2K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 655,795 | $832.9K | 0.00% | −73,887−10.1% | Reduced |
| BlackRock Inc. | 953,991 | $1.21M | 0.00% | +3240.0% | Added |
| Tang Capital Management LLC | 1,260,013 | $1.60M | 0.17% | −439,987−25.9% | Reduced |
| Vanguard Group Inc | 1,876,622 | $2.38M | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 2,435,129 | $3.09M | 0.00% | −44,066−1.8% | Reduced |
| Harbert Fund Advisors, Inc. | 5,175,913 | $6.57M | 4.52% | 00.0% | Unchanged |
| Anson Funds Management LP | 0 | $0 | 0.00% | −231,094−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −75,911−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −50,453−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −26,217−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −25,309−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,560−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Potomac Capital Management, Inc. | – | – | – | – | Not filed |